| DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.468 |
Evidence |
|
| DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.468 |
Evidence |
|
| DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.468 |
Evidence |
|
| CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.468 |
Evidence |
|
| CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
ABI1 |
ABI1, SSH3BP1: Abl interactor 1 |
0.468 |
Evidence |
|
| KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
0.468 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
0.468 |
Evidence |
|
| CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
0.468 |
Evidence |
|
| CDH6 |
CDH6: Cadherin-6 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.468 |
Evidence |
|
| EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.468 |
Evidence |
|